20 studies found for:    "Hansens disease"
Show Display Options
Rank Status Study
1 Active, not recruiting Virgin Coconut Oil Oral Supplementation for Leprosy Patients
Condition: Hansen's Disease
Interventions: Other: Multi-Drug Therapy (Novartis Ⓡ);   Dietary Supplement: Virgin Coconut Oil
2 Completed
Has Results
Leprosy Skin Test Antigens Trial
Condition: Leprosy
Interventions: Biological: Tuberculin, Purified Protein Derivative;   Other: MLSA-LAM;   Other: MLCwA;   Other: Placebo
3 Completed Molecular Epidemiology of Leprosy - Philippines
Condition: Leprosy
Intervention:
4 Completed Leprosy Skin Test Antigens Phase 1
Condition: Leprosy
Interventions: Biological: MLCwA;   Biological: MLSA-LAM;   Other: Mock Antigen
5 No longer available Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy
Condition: Leprosy
Intervention: Drug: clofazamine
6 Completed The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients
Condition: Leprosy
Interventions: Procedure: Routine treatment;   Radiation: Low level laser therapy (LLLT)
7 Completed Ciclosporin in the Management of New Type 1 Reactions in Leprosy
Condition: Leprosy
Interventions: Drug: Ciclosporin;   Drug: Prednisolone
8 Completed Microcirculatory Impairment in Patients With Leprosy
Condition: Lepromatous Leprosy
Interventions: Drug: acetylcholine Iontophoresis;   Drug: sodium nitroprusside Iontophoresis
9 Active, not recruiting Uniform Multidrug Therapy Regimen for Leprosy Patients
Condition: Leprosy
Interventions: Drug: PB 6 doses - Rifampicin and Dapsone;   Drug: PB 6 doses - Rifampicin, Clofazimine and Dapsone;   Drug: MB 12 doses - Rifampicin, Clofazimine and Dapsone;   Drug: MB 6 doses - Rifampicin, Clofazimine and Dapsone
10 Completed Effect of Additional Clofazimine on Erythema Nodosum Leprosum (ENL) Reactions in Leprosy
Conditions: Borderline Lepromatous Leprosy;   Lepromatous Leprosy
Interventions: Drug: Clofazimine;   Drug: Placebo
11 Completed Molecular and Immunological Tools for Detection of Strain Diversity, Drug Resistance and Immunological Responses
Condition: Leprosy
Intervention:
12 Completed Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in Leprosy
Condition: Leprosy
Intervention: Drug: ciclosporin
13 Completed Prevention of Disability: Proposal for a Guidance Manual for Leprosy Patients
Conditions: Leprosy;   Disability Evaluation;   Quality of Life
Intervention: Other: exercise and orientation
14 Completed Impact of the Virtual Human Project on Team-based Learning: A Randomized-controlled Trial
Condition: Leprosy
Intervention: Device: The Virtual Human Project
15 Unknown  Montelukast in ENL Reaction
Conditions: Erythema Nodosum Leprosum;   Leprosy
Intervention: Drug: montelukast in treatment of ENL reaction
16 Completed Ciclosporin in the Management of Chronic or Recurrent Erythema Nodosum Leprosum
Condition: Leprosy
Interventions: Drug: prednisolone;   Drug: ciclosporin
17 Completed Ciclosporin in the Management of New Erythema Nodosum Leprosum
Condition: Leprosy
Interventions: Drug: Ciclosporin;   Drug: prednisolone
18 Completed
Has Results
Effect of Weight and/or Obesity on Dapsone Drug Concentrations
Conditions: Obesity;   Leprosy;   Tuberculosis
Intervention: Drug: Dapsone
19 Recruiting Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer
Conditions: Muscle Injury;   Nerve Injury;   Poliomyelitis;   Leprosy;   Cerebral Palsy
Interventions: Procedure: Interosseous route of TPTT;   Procedure: Extra membranous route of TPTT
20 Recruiting Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
Conditions: Allergic Cutaneous Vasculitis;   Urticaria;   Psoriasis;   Acne;   Bullous Skin Diseases;   Sterile Pustulosis;   Leprosy;   Pneumocystis Pneumonia
Intervention: Drug: Dapsone

Study has passed its completion date and status has not been verified in more than two years.